The COVID-19 vaccine developed by British drug maker AstraZeneca Plc and Oxford University will likely be authorized for emergency use in the United States in April, the chief adviser for the U.S. COVID-19 vaccine program said on Wednesday.
U.S. officials unveiled details of their plan to distribute COVID-19 vaccines to millions of Americans starting later this month, as the United States again broke records for new coronavirus infections and hospitalizations.